Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

1 year ago 29

BRISBANE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

1. Homepage
2. category-label-
3. Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting